Literature DB >> 6155769

Influence of histamine or dimaprit on histamine release induced by anti-ige from human whole blood.

C Soubrane, B Lebel, C Burtin.   

Abstract

In human subjects histamine release from whole blood by anti-IgE and studied under several concentrations of histamine and dimaprit. The results obtained in our experiments led us to question the autoregulatory feed-back mechanism postulated by BOURNE et al. [1]. Apparently this mechanism does not apply for all patients particularly at doses which resemble physiological concentrations of histamine.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6155769     DOI： 10.1007/BF02024199

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


  4 in total

1.  A method for the fluorometric assay of histamine in tissues.

Authors:  P A SHORE; A BURKHALTER; V H COHN
Journal:  J Pharmacol Exp Ther       Date:  1959-11       Impact factor: 4.030

2.  Dimaprit -(S-[3-(N,N-dimethylamino)prophyl]isothiourea) - a highly specific histamine H2 -receptor agonist. Part 1. Pharmacology.

Authors:  M E Parsons; D A Owen; C R Ganellin; G J Durant
Journal:  Agents Actions       Date:  1977-03

3.  Human lung tissue and anaphylaxis: the effects of histamine on the immunologic release of mediators.

Authors:  M Kaliner
Journal:  Am Rev Respir Dis       Date:  1978-12

4.  Histamine augments leukocyte adenosine 3',5'-monophosphate and blocks antigenic histamine release.

Authors:  H R Bourne; K L Melmon; L M Lichtenstein
Journal:  Science       Date:  1971-08-20       Impact factor: 47.728
  4 in total
  2 in total

1.  In vitro influence of theophylline on anti-IgE-induced release from leucocytes and whole blood in asthmatic children.

Authors:  P Scheinmann; C Burtin; H Paupe; B Lebel; J Fermanian
Journal:  Agents Actions       Date:  1981-04

2.  A modulation of the anaphylactic basophil histamine release by selective H2 histamine agonists.

Authors:  W Kazimierczak; K Szczepaniak; K Bańkowska
Journal:  Agents Actions       Date:  1981-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.